Class Action Lawsuit Against Prevacid | 2026 Latest Updates

Plaintiffs claim Prevacid (lansoprazole), Takeda’s acid reducer, harmed their kidneys and, in some cases, led to gastric cancer. They say Takeda failed to adequately warn users of these risks. Takeda settled the U.S. Prevacid and Dexilant product liability cases on confidential terms. MDL No. 2789, the federal proton pump inhibitor litigation in New Jersey, remains on the docket. No Prevacid recall has been announced. People who took Prevacid or Prevacid SoluTab and later had a kidney diagnosis may fit the group the claims describe. Similar cases were filed against other PPI makers, including AstraZeneca, Procter & Gamble and Pfizer.

Latest Prevacid Lawsuit Updates

October 1, 2025: MDL 2789 Lists 11,331 Pending Actions

The Judicial Panel on Multidistrict Litigation report listed 11,331 actions pending in MDL No. 2789 [1]. Judge Claire C. Cecchi oversees it in the U.S. District Court for the District of New Jersey. In January 2023, Judge Cecchi’s Case Management Order No. 90 asked plaintiffs’ counsel in 104 cases to show why they should not be dismissed. The plaintiffs appeared to have died before the complaints were filed [2].

October 3, 2023: AstraZeneca Settles Nexium and Prilosec Cases

AstraZeneca announced settlement agreements in the Nexium and Prilosec product liability litigations and said it would pay $425 million [3]. The specific terms are confidential. That payment is not for Prevacid. Takeda, the maker of Prevacid, is a separate defendant. Read our Nexium lawsuit update for that litigation.

What Is Prevacid?

Prevacid and Prevacid SoluTab are proton pump inhibitors, or PPIs, says the FDA-approved label. It lists active duodenal ulcer in adults and acid reflux disease (GERD) among the uses [4]. Takeda Pharmaceuticals America, Inc. sells Prevacid. Takeda also sells Dexilant (dexlansoprazole), another PPI, and the same lawsuits name both drugs.

Who May Be Affected?

Doctors prescribe Prevacid and Prevacid SoluTab for duodenal and gastric ulcers, H. pylori infection, GERD and erosive esophagitis. People who took either medicine, or Dexilant, and later had a kidney diagnosis fit the group the lawsuits describe. Takeda disclosed that more than 6,100 product liability lawsuits about Prevacid and Dexilant had been filed in U.S. courts by March 31, 2024 [5]. Most went to one multidistrict litigation in New Jersey. Takeda reached an agreement in principle in April 2024. It signed a final written settlement in November 2024. Whether a person qualifies depends on an individual legal review, and Schmidt & Clark looks at each situation on its own facts.

Reported Injuries or Damages

Complaints in the Takeda litigation allege kidney injuries or, in some cases, gastric cancer. These are allegations only, not findings by a court. The FDA label, revised 11/2020, also warns about acute tubulointerstitial nephritis, a kidney problem. It says the condition “has been observed in patients taking PPIs and may occur at any point during PPI therapy.” The label tells doctors to stop Prevacid and check patients who may have this problem. A label warning does not show that Prevacid caused any plaintiff’s injury.

Evidence to Preserve

Keep records that show what you took, when you took it and what happened next:

• The prescription label or pharmacy records showing which PPI you took (Prevacid, Prevacid SoluTab or Dexilant), the dose and the dates of use
• Pharmacy and insurance records
• Medical records, kidney function tests and diagnoses
• Names of your treating doctors
• Photographs of pill bottles and packaging
• A written timeline of your symptoms
• Any letters or messages from doctors, pharmacies or manufacturers

Filing Deadlines

Filing deadlines come from state law. They vary with where a person lives and when the kidney injury and its diagnosis happened. In some states the clock starts at diagnosis. Waiting too long can end a Prevacid claim. Anyone with a kidney diagnosis after taking Prevacid should talk to a lawyer soon.

Frequently Asked Questions

Is There a Prevacid Lawsuit?

Yes, there is a Prevacid lawsuit. Takeda’s fiscal year 2026 filing lists product liability claims over Prevacid and Dexilant. The filing describes plaintiffs who allege kidney injuries or, in some cases, gastric cancer after taking either drug.

Did Takeda Settle the Prevacid Lawsuits?

Takeda did settle the Prevacid lawsuits. It established a provision for a non-material amount, and the terms are confidential. Takeda says the settlement had no material impact on its consolidated statements of profit or loss.

Is There a Prevacid Class Action in Canada?

Takeda’s fiscal year 2026 filing says one proposed class action is pending in Canada, in Saskatchewan. The filing lists it apart from the U.S. cases.

When Was Prevacid First Approved?

Prevacid received initial U.S. approval in 1995, according to its FDA-approved label. The current label covers Prevacid delayed-release capsules and Prevacid SoluTab orally disintegrating tablets.

What Should I Do If I Notice Kidney Problems While Taking Prevacid?

If you notice kidney problems while taking Prevacid, the Medication Guide in the FDA-approved label says to call your doctor right away. It names two signs: a decrease in the amount you urinate and blood in your urine.

References

1. https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-October-1-2025.pdf#page=1
2. https://www.njd.uscourts.gov/sites/njd/files/MDL2789_CMO90.pdf
3. https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-settles-nexium-and-prilosec-product-liability-litigations.html
4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020406s092%2C021428s039lbl.pdf
5. https://www.sec.gov/Archives/edgar/data/0001395064/000139506426000160/otheritemswhichareprovid.htm